http://www.dicerna.com
Dicerna Pharmaceuticals, Inc. Company Intro
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company using ribonucleic acid interference (RNAi) to develop medicines that silence genes that cause disease.
Industry
Healthcare
Dicerna Pharmaceuticals, Inc. Headquaters
33 Hayden Avenue
Lexington,02421
United States
Dicerna Pharmaceuticals, Inc. Share price
19 Jan 2021 01:31 GMT
$24.28
-0.07 (-0.29 %)
Dicerna Pharmaceuticals, Inc. Market cap
$1.769 B
WMC RANKING
2021
Dicerna Pharmaceuticals, Inc. # 130
BiotechnologyLatest Dicerna Pharmaceuticals, Inc. News
18 Jan 2021
Global High Mobility Group Protein B1 Market 2020-2028 Financial Insights Business Growth Strategies with Top Key Players: Affibody AB, Cantex Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Evec Inc, Ribomic Inc
Cantex Pharmaceuticals Inc; Dicerna Pharmaceuticals Inc; Evec Inc; Ribomic Inc. You can get free sample report includes TOC, Tables, and Figures of High ...
18 Jan 2021
COVID 19 Impact On Liver Diseases Therapeutics Market ...
Some of the Top companies are Astellas Pharma Inc., Bristol-Myers Squibb, Gilead ... Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo ...
18 Jan 2021
COVID 19 Impact On Chronic Liver Diseases Therapeutics ...
Some of the Top companies are Astellas Pharma Inc., Bristol-Myers Squibb, Gilead ... Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo ...
WMC Market Score
WMC Market to Revenue Score
Dicerna Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Dicerna Pharmaceuticals, Inc. | USD | $23,904 | $152,090 | $-120,459 | $17,690B | 130 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,660B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,740B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $586,520B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $274,470B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Dicerna Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Dicerna Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Dicerna Pharmaceuticals, Inc. | 0.26 | 2.12 | 18.03 | 0 | 0 | 0 | 10.35 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.03 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.18 | 100 | 60 | 0 | 0 | 90.52 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.94 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
